These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23408053)

  • 1. Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors.
    Sandoval F; Terme M; Nizard M; Badoual C; Bureau MF; Freyburger L; Clement O; Marcheteau E; Gey A; Fraisse G; Bouguin C; Merillon N; Dransart E; Tran T; Quintin-Colonna F; Autret G; Thiebaud M; Suleman M; Riffault S; Wu TC; Launay O; Danel C; Taieb J; Richardson J; Zitvogel L; Fridman WH; Johannes L; Tartour E
    Sci Transl Med; 2013 Feb; 5(172):172ra20. PubMed ID: 23408053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR6 deficiency impairs cancer vaccine efficacy and CD8
    Karaki S; Blanc C; Tran T; Galy-Fauroux I; Mougel A; Dransart E; Anson M; Tanchot C; Paolini L; Gruel N; Gibault L; Lepimpec-Barhes F; Fabre E; Benhamouda N; Badoual C; Damotte D; Donnadieu E; Kobold S; Mami-Chouaib F; Golub R; Johannes L; Tartour E
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination route matters for mucosal tumors.
    Nardelli-Haefliger D; Dudda JC; Romero P
    Sci Transl Med; 2013 Feb; 5(172):172fs4. PubMed ID: 23408051
    [No Abstract]   [Full Text] [Related]  

  • 4. Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model.
    Ishida E; Lee J; Campbell JS; Chakravarty PD; Katori Y; Ogawa T; Johnson L; Mukhopadhyay A; Faquin WC; Lin DT; Wirth LJ; Pierce RH; Pai SI
    Cancer Immunol Immunother; 2019 Aug; 68(8):1273-1286. PubMed ID: 31243491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8
    Melssen MM; Lindsay RS; Stasiak K; Rodriguez AB; Briegel AM; Cyranowski S; Rutkowski MR; Conaway MR; Melief CJM; van der Burg SH; Eyo U; Slingluff CL; Engelhard VH
    Cancer Immunol Res; 2021 May; 9(5):583-597. PubMed ID: 33619119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
    Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of resident memory T cells enhances the efficacy of cancer vaccine.
    Nizard M; Roussel H; Diniz MO; Karaki S; Tran T; Voron T; Dransart E; Sandoval F; Riquet M; Rance B; Marcheteau E; Fabre E; Mandavit M; Terme M; Blanc C; Escudie JB; Gibault L; Barthes FLP; Granier C; Ferreira LCS; Badoual C; Johannes L; Tartour E
    Nat Commun; 2017 May; 8():15221. PubMed ID: 28537262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.
    Sun YY; Peng S; Han L; Qiu J; Song L; Tsai Y; Yang B; Roden RB; Trimble CL; Hung CF; Wu TC
    Clin Cancer Res; 2016 Feb; 22(3):657-69. PubMed ID: 26420854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer.
    Mondini M; Nizard M; Tran T; Mauge L; Loi M; Clémenson C; Dugue D; Maroun P; Louvet E; Adam J; Badoual C; Helley D; Dransart E; Johannes L; Vozenin MC; Perfettini JL; Tartour E; Deutsch E
    Mol Cancer Ther; 2015 Jun; 14(6):1336-45. PubMed ID: 25833837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
    Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
    J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors.
    Bermúdez-Humarán LG; Cortes-Perez NG; Lefèvre F; Guimarães V; Rabot S; Alcocer-Gonzalez JM; Gratadoux JJ; Rodriguez-Padilla C; Tamez-Guerra RS; Corthier G; Gruss A; Langella P
    J Immunol; 2005 Dec; 175(11):7297-302. PubMed ID: 16301635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder.
    Domingos-Pereira S; Derré L; Warpelin-Decrausaz L; Haefliger JA; Romero P; Jichlinski P; Nardelli-Haefliger D
    J Urol; 2014 Mar; 191(3):814-22. PubMed ID: 23954582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravaginal Administration of Fc-Fused IL7 Suppresses the Cervicovaginal Tumor by Recruiting HPV DNA Vaccine-Induced CD8 T Cells.
    Choi YW; Kang MC; Seo YB; Namkoong H; Park Y; Choi DH; Suh YS; Lee SW; Sung YC; Jin HT
    Clin Cancer Res; 2016 Dec; 22(23):5898-5908. PubMed ID: 27407095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prime-Boost Vaccination Approach Induces Lung Resident Memory CD8+ T Cells Derived from Central Memory T Cells That Prevent Tumor Lung Metastasis.
    Xu H; Yue M; Zhou R; Wang P; Wong MY; Wang J; Huang H; Chen B; Mo Y; Tam RC; Zhou B; Du Z; Huang H; Liu L; Tan Z; Yuen KY; Song Y; Chen H; Chen Z
    Cancer Res; 2024 Oct; 84(19):3173-3188. PubMed ID: 39350665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine.
    Smalley Rumfield C; Pellom ST; Morillon Ii YM; Schlom J; Jochems C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal Administration of
    Wang Y; An EK; Kim SJ; You S; Jin JO
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY; Park SH; Nam HJ; Choi DH; Sung YC
    J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity.
    Kataoka K; McGhee JR; Kobayashi R; Fujihashi K; Shizukuishi S; Fujihashi K
    J Immunol; 2004 Mar; 172(6):3612-9. PubMed ID: 15004163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.